AIM ImmunoTech Inc. (AIM) › Net IncomeAIM ImmunoTech Inc. (AIM) — Net IncomeAnnual figures by fiscal year, from SEC filings.2013: -$16.23M2014: -$17.45M2015: -$15.23M2016: -$7.50M2017: -$8.26M2018: -$9.83M2019: -$9.40M2020: -$14.40M2021: -$19.13M2022: -$19.45M2023: -$28.96M2024: -$17.32M2025: -$13.96M-$13.96M2013Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$13.96M+19.4%2024-$17.32M+40.2%2023-$28.96M-48.9%2022-$19.45M-1.7%2021-$19.13M-32.8%2020-$14.40M-53.1%2019-$9.40M+4.3%2018-$9.83M-19.0%2017-$8.26M-10.1%2016-$7.50M+50.7%2015-$15.23M+12.7%2014-$17.45M-7.6%2013-$16.23M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share